Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis
Nat Med
.
2024 Apr;30(4):925-926.
doi: 10.1038/s41591-024-02818-w.
Authors
Stefano Alivernini
1
2
3
4
,
Juan D Cañete
5
,
Jaume Bacardit
6
,
Mariola Kurowska-Stolarska
7
Affiliations
1
Immunology Research Core Facility, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. stefano.alivernini@policlinicogemelli.it.
2
Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. stefano.alivernini@policlinicogemelli.it.
3
Division of Rheumatology, Università Cattolica del Sacro Cuore, Rome, Italy. stefano.alivernini@policlinicogemelli.it.
4
Research into Inflammatory Arthritis Centre Versus Arthritis (RACE), University of Glasgow, Glasgow, UK. stefano.alivernini@policlinicogemelli.it.
5
Rheumatology Department, Hospital Clinic and FCRB-IDIBAPS, Barcelona, Spain.
6
Interdisciplinary Computing and Complex BioSystems (ICOS) Research Group, School of Computing, Newcastle University, Newcastle, UK.
7
Research into Inflammatory Arthritis Centre Versus Arthritis (RACE), University of Glasgow, Glasgow, UK. Mariola.kurowska-stolarska@glasgow.ac.uk.
PMID:
38361121
DOI:
10.1038/s41591-024-02818-w
No abstract available
Publication types
Letter
MeSH terms
Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / drug therapy
Artificial Intelligence
Humans
Substances
Antirheumatic Agents
Grants and funding
19213/VAC_/Versus Arthritis/United Kingdom
22272/VAC_/Versus Arthritis/United Kingdom
MR/V036998/1/MRC_/Medical Research Council/United Kingdom